Bridge Biotherapeutics, Inc. engages in the provision of manufacturing of pharmaceutical products. It also engages in the provision pharmacy research, development, and experimentation of medicines. The company was founded by Jeong-Gyu, Lee on September 17, 2015 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company